ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,213.49
0.51%
Dow Jones
38,675.68
1.18%
Gold vs US Dollar
2,302.57
0.00%
Brent Oil
82.765
0.00%
Bitcoin
63,367.66
0.76%
Pepperstone
Advertisement
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Oncternal Therapeutics Inc (ONCT)

  7. Oncternal Therapeutics Inc (ONCT) News

Oncternal Therapeutics (ONCT)

Oncternal Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ONCT
DateTimeSourceHeadlineSymbolCompany
08/03/202421:42Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:ONCTOncternal Therapeutics Inc
07/03/202421:20Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:ONCTOncternal Therapeutics Inc
07/03/202421:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ONCTOncternal Therapeutics Inc
27/02/202422:02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ONCTOncternal Therapeutics Inc
15/02/202423:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ONCTOncternal Therapeutics Inc
15/02/202423:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ONCTOncternal Therapeutics Inc
15/02/202423:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ONCTOncternal Therapeutics Inc
15/02/202423:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ONCTOncternal Therapeutics Inc
23/01/202421:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ONCTOncternal Therapeutics Inc
05/01/202421:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ONCTOncternal Therapeutics Inc
05/01/202421:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ONCTOncternal Therapeutics Inc
05/01/202421:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ONCTOncternal Therapeutics Inc
05/01/202421:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ONCTOncternal Therapeutics Inc
05/01/202421:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ONCTOncternal Therapeutics Inc
09/11/202321:30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ONCTOncternal Therapeutics Inc
09/11/202321:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ONCTOncternal Therapeutics Inc
06/10/202321:31Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ONCTOncternal Therapeutics Inc
04/10/202322:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ONCTOncternal Therapeutics Inc
04/10/202322:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ONCTOncternal Therapeutics Inc
04/10/202321:59Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ONCTOncternal Therapeutics Inc
04/10/202321:59Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ONCTOncternal Therapeutics Inc
14/09/202321:01Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:ONCTOncternal Therapeutics Inc
10/08/202321:30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ONCTOncternal Therapeutics Inc
10/08/202321:11Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ONCTOncternal Therapeutics Inc
05/07/202323:59Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ONCTOncternal Therapeutics Inc
05/07/202323:58Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ONCTOncternal Therapeutics Inc
05/07/202323:58Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ONCTOncternal Therapeutics Inc
05/07/202323:57Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ONCTOncternal Therapeutics Inc
30/06/202321:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ONCTOncternal Therapeutics Inc
30/06/202321:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ONCTOncternal Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:ONCT

Your Recent History

LSE
SCLP
Scancell
LSE
AGL
Angle
LSE
FUM
Futura Medical
LSE
EEE
Empire Metals
LSE
AAU
Ariana Resources
LSE
GFM
Griffin Mining
LSE
SCE
Surface Transforms
LSE
PHNX
Phoenix
LSE
HARL
Harland & Wolff
LSE
TERN
Tern
LSE
GKP
Gulf Keystone Petroleum
LSE
BEN
Bens Creek
LSE
GOLD
LSE
AAZ
Anglo Asian Mining
LSE
AAL
Anglo American
LSE
MIN
Minoan
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved